Ayurvedic management of Tamaka Shwasa with Sadyovamana and Vyaghrijeerakadi Leha in children

Efficacy of Sadyovamana and Vyaghrijeerakadi Leha in the management of Tamaka Shwasa (Asthma) in children An open labelled single arm clinical trial. - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/03/082653

Enrollment

Registered

2025-03-18

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J453- Mild persistent asthma

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient presenting with minimum 4 classical symptoms of Tamaka Shwasa (Asthma) which are mentioned in diagnostic criteria. 2. Patient having symptoms of Utklishta Kapha i.e. Kaphaja Kasa, Hrillas, Praseka, Annadvesha, Ghurghuraka, Kapha Nishthivana. 3. At least 2 episodes of Asthma attack during last 1 year. 4. Patients on MDI or taking nebulization on & off of short or long-acting bronchodilator

Exclusion criteria

Exclusion criteria: 1. Evidence of requirement of intubations for Asthma, or had been hospitalized for asthma within one month before. 2. Unresolved sinus disease or an unresolved Upper or Lower respiratory tract infection within 4 weeks. 3. Known case of systemic illnesses such as TB, HIV and other chronic debilitating diseases. 4. Known case of active pulmonary disease other than Asthma.

Design outcomes

Primary

Measure	Time frame
1. AEC (Absolute Eosinophil Count) (BT, AT) 2. PRAM (Pediatric Respiratory Assessment Measure) (BT, AT) 3. Frequency of nebulization (BT, AT) 4. Spirometer (FEV1) (BT, AT) (Before Vamana, After Vamana) Timepoint: 57 days	—

Secondary

Measure	Time frame
1. Improvement in Tamaka Shwasa symptoms i.e. Shwasakrichhrata, Ghurghurukam, Kasa, Pinasa, Parshva Shula, Kapha Nishthivana, Kanthodhwansa, Anidra, Ushnabhinanditi (BT, AT) Annexure-III 2. Total frequency of the acute episodes of asthma during last two months (BT, AT) 3. ACT (Asthma Control Test) (BT, AT) Annexure-I 4. Breath holding time (BT, AT) 5. PEFR (Peak Expiratory Flow Rate) (BT, AT), (Before Vamana, After Vamana) 6. Respiratory Rate (BT, AT) (Before Vamana, After Vamana) Timepoint: 57 days	—

Measure

Time frame

1. Improvement in Tamaka Shwasa symptoms i.e. Shwasakrichhrata, Ghurghurukam, Kasa, Pinasa, Parshva Shula, Kapha Nishthivana, Kanthodhwansa, Anidra, Ushnabhinanditi (BT, AT) Annexure-III 2. Total frequency of the acute episodes of asthma during last two months (BT, AT) 3. ACT (Asthma Control Test) (BT, AT) Annexure-I 4. Breath holding time (BT, AT) 5. PEFR (Peak Expiratory Flow Rate) (BT, AT), (Before Vamana, After Vamana) 6. Respiratory Rate (BT, AT) (Before Vamana, After Vamana) Timepoint: 57 days

—

Countries

India

Contacts

Public ContactDr Sagar M Bhinde

Institute of Teaching and Research in Ayurveda, Jamnagar

sgrbhinde@gmail.com9662512158

Outcome results